WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals, Inc., a clinical-stage life science company developing a portfolio of potent new antibiotics designed to be effective against dangerous, drug-resistant bacteria, including multidrug-resistant (MDR) gram-negative pathogens, today announced that executives from the company are scheduled to present at the following conferences in October and November:
•The 10th Annual BIO Investor Forum on October 25-26, 2011, at The Palace Hotel, San Francisco, California •GTC’s 8th Anti-Infectives Partnering and Deal-Making Conference on November 7-8, 2011, The Omni Parker House in Boston, Massachusetts •Lazard Capital Markets 8th Annual Healthcare Conference on November 15-16, 2011, at the Pierre Hotel, New York, New York •The 2011 Chemical and Biological Defense Science and Technology (CBD S&T) Conference on November 14-18, 2011, at the Mirage Hotel, Las Vegas, Nevada
•The 10th Annual BIO Investor Forum on October 25-26, 2011, at The Palace Hotel, San Francisco, California •GTC’s 8th Anti-Infectives Partnering and Deal-Making Conference on November 7-8, 2011, The Omni Parker House in Boston, Massachusetts •Lazard Capital Markets 8th Annual Healthcare Conference on November 15-16, 2011, at the Pierre Hotel, New York, New York •The 2011 Chemical and Biological Defense Science and Technology (CBD S&T) Conference on November 14-18, 2011, at the Mirage Hotel, Las Vegas, Nevada
